|
|
regurgitation
|
|
|
*[ri,gә:dʒi'teiʃәn]\nn. 回流, 逆流, 反刍\n【医】 回流, 反流, 反胃
|
| 分类：
|
详细解释：
|
|
|
以下为句子列表：
英文: Background— Mild commissural mitral regurgitation (MR) is associated with significantly higher restenosis-free surial after percutaneous mitral aluloplasty (PM), which suggests that different mechanisms of significant MR after PM may hae different clinica
中文: 背景：经皮二尖瓣成形术后严重高度非再狭窄存活率与轻度交界处损伤的二尖瓣关闭不全相关，表明经皮二尖瓣成形术后严重二尖瓣关闭不全的不同机制可能有不同的临床过程。
更详细...
英文: Conclusions The frequency of clinically important valve regurgitation was significantly increased in patients taking pergolide or cabergoline, but not in patients taking non–ergot-derived dopamine agonists, as compared with control subjects.
中文: 结论：与对照组相比，服用培高利特或者卡麦角林的患者临床上发生重要瓣膜返流的频率显著增加，但服用非麦角洐生的多巴胺受体激动剂的患者瓣膜返流的发生率却未增加。
更详细...
英文: Patients treated with ergot derivatives who had grade 3 to 4 regurgitation of any valve had received a significantly higher mean cumulative dose of pergolide or cabergoline than had patients with lower grades.
中文: 在服用麦角洐生物进行治疗的患者中，发生任何瓣膜3到4级返流的患者服用培高利特或卡麦角林的平均累积剂量显著高于瓣膜返流级别较低的患者。
更详细...
英文: Results Clinically important regurgitation (moderate to severe, grade 3 to 4) in any valve was found with significantly greater frequency in patients taking pergolide (23.4%) or cabergoline (28.6%) but not in patients taking non–ergot-derived dopamine ago
中文: 结果：与对照组相比（5.6%），服用培高利特（23.4%）或者卡麦角林的患者（28.6%），临床上发生重要的任何瓣膜的返流（中到重度，3级到4级）的频率显著升高，而服用非麦角洐生的多巴胺受体激动剂的患者（0%）瓣膜返流的发生率却未增加。
更详细...
英文: Results The clinical symptoms were multiple,including melena in cases(00%),hematemesis in 0 cases(7.%),abdominal distention in cases(8 . %),abdominal pain in 9 cases(.%) and acid regurgitation in 8 cases(.9%).
中文: 果例患者临床表现为黑便例(00%)、呕血 0例(7.%)、腹胀 例(8 . %)、腹痛9例(.%)、反酸8例(.9%)。
更详细...
|
|
|
|
|
